We have generated a nuclease resistant RNA-aptamer, named CL4, that binds at high affinity to the extracellular domain IV of human EGFR and inhibits the receptor in non-small cell lung carcinoma (NSCLC) and glioblastoma (GBM)24, 25, 26. Here, EGFR is linked to non-small cell lung carcinoma.